DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Food, Beverage & Tobacco
Published
07 Nov 24
Updated
03 Sep 26
Views
326
Not Invested
Japan Tobacco2914
2914 logo
Fair Value
JP¥7.23k
Share price03 Sep
JP¥6.77k6.3% undervalued intrinsic discount
Loading
1Y42.71%
7D2.47%

2914: Profit Margin Gains And Dividend Outlook Will Support Measured Performance

AN
AnalystConsensusTarget
AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
07 Nov 24
Updated
03 Sep 26
Views
326
Not Invested
Fair ValueJP¥7.23k
Share priceJP¥6.77k
6.3% undervalued intrinsic discount
Narrative
Updates29

Last Update 03 Sep 26

Fair value Increased 7.83%

2914: Combustible Share Execution And Dividend Policy Will Support Future Balanced Returns

Japan Tobacco’s analyst price target has been revised from ¥6,706.67 to ¥7,232.08, with analysts pointing to the company’s focus on combustible share and expectations for continued strong delivery as key drivers of the update.

What’s in the News for Japan Tobacco

  • Japan Tobacco announced a second quarter cash dividend of ¥136.00 per share for the period ended June 30, 2026, compared with ¥104.00 per share for the same quarter a year earlier. The dividend is payable on September 1, 2026. Source: Company dividend announcement.
  • For the full year ending December 31, 2026, Japan Tobacco expects to pay a total dividend of ¥136.00 per share, compared with ¥130.00 per share for the prior year. Source: Company dividend guidance.
  • Japan Tobacco revised earnings guidance for the fiscal year ending December 31, 2026, with projected revenue of ¥3,885.0b, operating profit of ¥1,008.0b, profit attributable to owners of parents of ¥644.0b, and basic earnings per share of ¥362.74. Source: Company earnings guidance.
  • The board of Japan Tobacco held a meeting on June 5, 2026, to consider disposal of treasury shares for restricted stock remuneration and performance share units, along with other business matters. Source: Company board meeting disclosure.

Valuation Changes for Japan Tobacco

  • Fair value has risen from ¥6,706.67 to ¥7,232.08, which is an increase of about 7.8%.
  • The discount rate is almost unchanged, moving slightly from 5.78% to 5.78% on a rounded basis.
  • The revenue growth expectation is marginally lower, shifting from 5.37% to about 5.34%.
  • The net profit margin has risen from 18.57% to about 19.76%, indicating a slightly higher assumed profitability for Japan Tobacco.
  • The future P/E multiple has edged lower from 18.06x to about 17.68x, implying a slightly lower valuation multiple applied to expected earnings.
Read more
1 viewusers have viewed this narrative update

Key Takeaways

  • Expansion into reduced-risk products and premium offerings drives sustained margin improvement, while innovation investment secures future earnings growth.
  • International acquisitions and market share gains offset declines in mature markets, diversifying revenue and strengthening global competitive positioning.
  • Heavy reliance on declining domestic markets, unprofitable reduced-risk products, and global regulatory, economic, and foreign exchange risks threaten profitability and revenue stability.

Catalysts

About Japan Tobacco
    A tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally.
What are the underlying business or industry changes driving this perspective?
  • Expansion of harm-reduction products like Ploom AURA and EVO addresses evolving consumer preferences for reduced-risk options, with segment share gains and plans for accelerated international rollout supporting sustained future revenue growth and improved net margins over the medium term.
  • Strategic acquisitions (notably Vector Group in the U.S.) and continued international market share gains, especially in emerging markets with rising disposable incomes and expanding middle classes, position Japan Tobacco to offset volume declines in mature geographies and drive long-term revenue and operating profit diversification.
  • Robust pricing power and portfolio premiumization, evidenced by successful launches at higher price points (e.g., premium EVO sticks) and effective price increases in markets like the Philippines, Italy, and the UK, underpin resilience in core revenue and the potential for sustainable net margin expansion.
  • Ongoing R&D investment and a targeted ¥650 billion global allocation for innovation in next-generation products and marketing are likely to future-proof earnings and accelerate the path to profitability in the company's Reduced-Risk Product segment, positively impacting margins and long-term earnings growth.
  • Industry-wide consolidation and shifting regulatory landscape create barriers to entry and enable further scale efficiencies for large incumbents like Japan Tobacco, bolstering competitive positioning and enabling improved operating leverage and bottom-line growth in less-regulated, high-potential regions.
Japan Tobacco Earnings and Revenue Growth

Japan Tobacco Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Japan Tobacco's revenue will grow by 5.3% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 16.4% today to 19.8% in 3 years time.
  • Analysts expect earnings to reach ¥859.2 billion (and earnings per share of ¥484.01) by about September 2029, up from ¥610.0 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ¥1006.0 billion in earnings, and the most bearish expecting ¥710.9 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 17.7x on those 2029 earnings, down from 20.4x today. This future PE is lower than the current PE for the JP Tobacco industry at 20.4x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.78%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The company is heavily reliant on the Japanese domestic tobacco market, which continues to experience year-on-year declines in combustibles industry volume and overall market contraction, directly threatening a core source of revenue and profits.
  • There is ongoing evidence of down-trading in key Asian and emerging markets, including Japan and the Philippines, where consumers shift to lower-priced products in response to price increases and weaker economic sentiment, eroding revenue growth and net margin expansion.
  • While reduced-risk products (RRPs) and heated-tobacco (HTS) devices are showing growth, management indicates the RRP segment as a whole remains unprofitable, requiring massive investment (¥650 billion over three years) and is only targeting breakeven by 2028, meaning RRPs are a drag on overall group earnings until then.
  • Foreign exchange volatility remains a persistent risk, as significant overseas earnings (especially from emerging markets) are subject to yen strength, with negative FX impacts already weighing on AOP and reported earnings, contributing potential downside to net margins and profit growth.
  • The industry continues to face global regulatory tightening, litigation costs (e.g., Canadian settlements), tax hikes, and possible new tariffs, all of which can compress profit margins, increase operating costs, and reduce legitimate demand-negatively impacting top-line revenue and overall profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of ¥7232.08 for Japan Tobacco based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥8400.0, and the most bearish reporting a price target of just ¥6100.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ¥4347.3 billion, earnings will come to ¥859.2 billion, and it would be trading on a PE ratio of 17.7x, assuming you use a discount rate of 5.8%.
  • Given the current share price of ¥7003.0, the analyst price target of ¥7232.08 is 3.2% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Japan Tobacco?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

2914 logo
Japan Tobacco
11.0% overvalued intrinsic discount

Global Regulation And Combustible Decline Will Erode Tobacco Earnings Power Over Time

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 19 Aug
Read Narrative
2914 logo
Japan Tobacco
19.0% undervalued intrinsic discount

Heated Tobacco Expansion And RRP Investment Will Transform Long Term Earnings Quality

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 5 Aug
Read Narrative

Fair Value vs Share Price

JP¥7.23k
vs JP¥6.77k6.3% undervalued intrinsic discount
PastFuture04t2015201820212024202620272029Revenue JP¥4.3tEarnings JP¥859.2b
5.3%
Revenue growth
19.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Japan Tobacco

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Solid track record with excellent balance sheet and pays a dividend.

Market capJP¥12.0t
PB2.7x
Estimated Growth4.8%
Dividend Yield4.0%
Full analysis

CEO & management

Takehiko Tsutsui
CEO
2.9yrs
CEO Tenure

A tobacco company, engages in the manufacture and sale of tobacco products in Japan and internationally.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide